Genetically engineered mouse models deficient in genes such as Brca1 and p53 exhibit pre‐neoplastic events such as increased numbers of mammary stem/progenitors and hyperplasia followed by multiple mammary tumors (Brodie et al, 2001; Evers & Jonkers, 2006). This evidence concerns the gene TP53 and breast cancer.